2009年3月19日 · Patients with the characteristic moyamoya vasculopathy who also have well-recognized associated conditions (described below) are categorized as having the moyamoya syndrome, whereas...

When there is associated disease, it is known as moyamoya syndrome. Treatments are currently limited, although surgical revascularization may prevent ischemic events and preserve quality of life. In this review, we summarize recent advances in moyamoya disease, covering aspects of epidemiology, etiology, presentation, imaging, and treatment ...

2023年8月23日 · Adult moyamoya disease and syndrome are rare disorders with significant morbidity and mortality. A writing group of experts was selected to conduct a literature search, summarize the current knowledge on the topic, and provide a road map for future investigation.

2021年7月8日 · Moyamoya disease and moyamoya syndrome both reduce blood flow to the brain, increasing the risk of stroke. UT Southwestern discusses the difference between the two conditions, how we treat them, and how to reduce your risks.

2023年7月7日 · The term moyamoya disease (MMD) is used when the condition is idiopathic and not associated with another disease or due to a genetic susceptibility; moyamoya syndrome (MMS) is used when vascular findings occur in the presence of an associated condition, such as sickle cell disease.

Moyamoya is a progressive disorder that may lead to ischemic stroke or intracranial hemorrhage in children and adults. This topic will review the etiologies, clinical features, and diagnosis of moyamoya.

2023年6月25日 · Moyamoya disease (MMD) is an isolated chronic, usually bilateral, vasculopathy of undetermined etiology characterized by progressive narrowing of the terminal intracranial portion of the internal carotid artery and circle of Willis.

2019年10月4日 · Objective: Phenotypic differences between moyamoya disease (MMD) and moyamoya syndrome (MMS) remain unclear. The purpose of this study was to evaluate whether such differences exist when presentation, procedure-related, and outcome variables are compared quantitatively.

2019年10月4日 · Phenotypic differences between moyamoya disease (MMD) and moyamoya syndrome (MMS) remain unclear. The purpose of this study was to evaluate whether such differences exist when presentation, procedure-related, and …

In this review, we summarize recent advances in moyamoya disease, covering aspects of epidemiology, etiology, presentation, imaging, and treatment strategies. Keywords: Cerebral arterial diseases; Cerebral revas-cularization; Cerebrovascular disorders; Intracranial arterial diseases; Moyamoya disease.